Skip to content
CNS Clinical Research

South Dakota

CNS clinical trials in South Dakota

11 CNS studies are recruiting participants at sites in 4 cities across South Dakota as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every South Dakota city with a recruiting study

By research area: Parkinson's Disease (6), Depression (3), Epilepsy (1), Migraine (1).

Sioux Falls (10), Rapid City (2), Pine Ridge (1), Yankton (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in South Dakota

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Lakota Family Acceptance Project Pilot RCT

    • No phase
    • Ages 13 and older
    • All sexes
    Sponsor
    University of Michigan
    Recruiting in
    Pine Ridge · Rapid City
    Registry record
    NCT07865858 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Rapid City · Sioux Falls
    Registry record
    NCT06748222 · updated
  3. A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Sioux Falls
    Registry record
    NCT07412756 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in South Dakota on ClinicalTrials.gov.

Parkinson's disease: recently updated in South Dakota

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Sioux Falls
    Registry record
    NCT06989112 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls · Yankton
    Registry record
    NCT06966700 · updated
  3. KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT07252739 · updated
  4. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Sioux Falls
    Registry record
    NCT07174310 · updated
  5. KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT04165070 · updated
  6. KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT04165798 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in South Dakota on ClinicalTrials.gov.

Epilepsy: recently updated in South Dakota

  1. Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

    • Observational
    • All ages
    • All sexes
    Sponsor
    Sanford Health
    Recruiting in
    Sioux Falls
    Registry record
    NCT01793168 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in South Dakota on ClinicalTrials.gov.

Migraine: recently updated in South Dakota

  1. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Sioux Falls
    Registry record
    NCT05156398 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in South Dakota on ClinicalTrials.gov.

Ask about studies in South Dakota

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call